http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106645725-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106645725-B |
| titleOfInvention | Differentiate product and method as the hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma of marker based on MANF |
| abstract | The invention discloses differentiate product and method as the hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma of marker based on MANF.The present invention provides the systems of detection MANF expression quantity to prepare the application identified or assisting in differentiating patients with hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma patient product.The present invention is by regarding MANF as marker, by detecting expressions of the MANF in primary carcinoma of liver tumor tissues, differentiate hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma, establish the means and index for effectively differentiating hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma, its sensitivity is 92.5%, specificity 74.7%, to carry out specific aim rational therapy, the prognosis for improving patient is laid a good foundation to improve patients ' life quality and mitigate patient economy burden. |
| priorityDate | 2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.